COVID-19-Associated Encephalopathy: A Case Series Demonstrating the Rapid Deterioration of Mental Status and a Review of the Literature
- PMID: 39834950
- PMCID: PMC11743337
- DOI: 10.7759/cureus.76005
COVID-19-Associated Encephalopathy: A Case Series Demonstrating the Rapid Deterioration of Mental Status and a Review of the Literature
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is known for its severe inflammatory response, often leading to multi-organ dysfunction. Among the less-recognized complications is COVID-19-associated encephalopathy, particularly in the elderly, where it contributes significantly to morbidity and mortality. This report explores the rapid neurocognitive decline observed in six hospitalized patients with COVID-19, with or without pre-existing neurological conditions. Each case highlights the challenges of managing complex clinical courses and emphasizes the importance of early, multidisciplinary intervention, including palliative care, to address the goals of care. Given the underreporting of COVID-19-associated encephalopathy, this case series underscores the need for increased awareness and specialized care to improve patient outcomes, particularly in older populations.
Keywords: care disposition; cognitive impairment; covid-19; delirium; encephalopathy.
Copyright © 2024, Reny et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Jefferson Office of Human Research Institutional Review Board issued approval 2023-2401. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures





Similar articles
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
The impact of COVID-19 pandemic on elderly with neurocognitive disorders.Psychiatriki. 2023 Oct 12;34(3):177-180. doi: 10.22365/jpsych.2023.018. Epub 2023 Jul 14. Psychiatriki. 2023. PMID: 37449850 English, Greek, Modern.
-
Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19.Neurocrit Care. 2021 Dec;35(3):693-706. doi: 10.1007/s12028-021-01220-5. Epub 2021 Mar 16. Neurocrit Care. 2021. PMID: 33725290 Free PMC article.
-
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23. J Neurol. 2021. PMID: 33486564 Free PMC article. Review.
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
References
-
- Encephalopathy in patients with COVID-19: a review. Garg RK, Paliwal VK, Gupta A. J Med Virol. 2021;93:206–222. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous